Share This Article:

New Design of Biopharmaceuticals through the Use of Microalgae Addressed to Global Geopolitical and Economic Changes. Are You Ready for New Development in Biopharma?

Abstract Full-Text HTML Download Download as PDF (Size:74KB) PP. 33-38
DOI: 10.4236/pp.2010.11005    5,391 Downloads   10,061 Views   Citations

ABSTRACT

The Biopharma industry is enduring sweeping change in response to the financial crisis, but one aspect of the in-dustry that emerged relatively unscathed and that perhaps has directly benefited from the crisis is new revolutionary innova- tion solution. Identifying opportunities in the next wave of technologies for Biopharma, along with other policy initia- tives including financial crisis actions and climate policy, will affect on manufacturing biopharmaceutical products today and in the future in cost effective manner, and will be our adequate answer addressing to global geopolitical, economic and climate changes. It also underscores the search for new approach, evidenced by trends around new for- mulations to serve lower income patients. Microalgae biomass comes in many strains, and can be used by means of variety product developments. In the last years the key task of our R & D was to find a solution for these tasks. The bio- fuel market development dynamics include significant opportunity of microalgae raw material and microalgae proc- essing biomass rest of biodiesel manufacturing for Biopharma global growth in cost effective manner. Second new source of microalgae raw material for Biopharma include microalgae production through waste and wastewater cleaning. This should provide the opportunity to see the future in a new vision, where technology can serve as a revela- tion of the truth and where every endeavor is governed by reflection on and appreciation of the environment and thus leading to resolution of global tasks facing the world community and inclusion of microalgae in production and bio cycles open new cost effective ways for Biopharma companies and conservation of nature. A truly coherent microalgae raw material and Biopharma production policy has to find ways to bring these two traces closer for cost effective manufacturing, well being Biopharma economy and human health.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

A. Avagyan, "New Design of Biopharmaceuticals through the Use of Microalgae Addressed to Global Geopolitical and Economic Changes. Are You Ready for New Development in Biopharma?," Pharmacology & Pharmacy, Vol. 1 No. 1, 2010, pp. 33-38. doi: 10.4236/pp.2010.11005.

References

[1] J. Wechdier, “Issue and Opportunities Challenge Biotech Manufacturers,” Biopharm International, Vol. 23, No. 1, 2010, pp. 16-17.
[2] M. Hoffman, “Parallel Track. Obama Cost-Containment and Science Innovation Initiatives Need to Overlap,” Pharmateuticals Technology, Vol. 33, No. 4, April, 2009, p. 12.
[3] E. C. Langer, M. Pavicant, “Global Economic Crunch. Benefits Biomanufacturing Outsourcing to Asia,” Inside Outsoursing, November 2009, pp. 24-28.
[4] D. C. Esola, “An Introduction from the Publisher,” Inside Outsoursing, November 2009, p. 8. http://www.nxtbook. com/nxtbooks/advanstar/insideoutsourcing_200911/#/10/ OnePage.
[5] A. C. Cacich, R. Bjella, M. J. Cosko, et al., “8 Key Players. On The Future of Global Outsourcing, and Forming Alliances with CRO’s/CMO’s,” Inside Outsoursing, No-vember 2009, pp. 32-37.
[6] http://www.nxtbook.com/nxt-books/advanstar/insideoutsourcing_200911/#/32/OnePage. [6] A. B. Avagyan, “A Contribution to Global Sustainable Development: Inclusion of Microalgae and their Biomass in Production and Bio Cycles,” Clean Technologies and Environmental Policy, Vol. 10, No. 4, 2008, pp. 313-317.
[7] A. B. Avagyan, “New Design & Build Biological System through the Use of Microalgae Addressed to Sustainable Development,” Journal of Environmental Protection, Vol. 1, No. 2, 2010, pp. 183-200.
[8] A. B. Avagyan, “Global Prospects for Microalgae Pro- duction for Biofuels and for the Preservation of Nature,” Global Fuel Magazine, February 2008, pp. 22-27. http://www.propubs.com/global-fuels/eGF_Feb08_LowRes.pdf
[9] J. Lane, “Advanced Biofuels Tracking Database,” Biofuels Digest, March 2010. http://www.biofuelsdigest.com/bdi- gest/2010/03/23/advanced-biofuels-tracking-database/
[10] A. B. Avagyan, “Microalgae Production Development Glo- bal Prospects and Profitable Technology Wasterwater Purification by the Use Microalgae,” Water and Wastewater International, 2008. http://ww.pennnet.com/articles/article_ dis-play.cfm?article_id=340236&dcmp=WaterWorldEnl
[11] A. B. Avagyan, “Microalgae: Big Feed Potential in a Small Package,” Feed International, March 2008, pp. 16-18. http://www.fi-digital.com/fi/200803/data/feedinternational200803-win32.zip
[12] Y.-K. Lee, “Commercial Production of Microalgae in the Asia-Pacific Rim,” Journal of Applied Phycology, Vol. 9, No. 5, October 1997, pp. 403-411.
[13] Cyanotech Corp.,“BioAstin.”’ http://www.cyanotech.com/bioastin.html
[14] The Colon Cleansing & Constipation Resource Center, “How Chlorella Relates to Constipation,” 2007. http://www.articlesbase.com/alternative-medicine-articles/how-chlorella-relates-to-constipation-89878.html
[15] J. A. Del Campo, M. García-González, M. G. Guerrero, “Outdoor Cultivation of Microalgae for Carotenoid Pro-duction: Current State and Perspectives,” Applied Micro-biology and Biotechnology, Vol. 74, No. 6, 2007, pp. 1163- 1174.
[16] H. Chapell, “PhD Presents Omega-3 Replacements for Medical Fish Oils,” February 2009. http://www.chiroeco. com/chiropractic/news/7480/856/PhD-presents-Omega-3- replacements-for-medical-fish-oils/
[17] J. Lane, “BioCentric to Deploy Five Algae Photobioreac- tor Units in Client Trial,” Biofuels Digest, April 2010. http://biofuelsdigest.com/bdigest/2010/04/23/biocentric-to-deploy-five-algae-photobioreactor-units-in-client-trial/

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.